Sinclair Pharma has reported H1 ##M revenues of £ 22 m ( $ 27.2 m ) , an increase of 16 % on last year 's figure of £ 20 m . “Strong cost discipline ... The increase is attributed to strong demand for Sinclair 's aesthetic dermatology products in Brazil . Sinclair also said Silhouette Soft sales were up 20 % to £ 7.3 m , and first - sales for Silhouette InstaLift hit £ 2.3 m . Even better results are expected in the second half of the year , according to CEO Chris Smith .
Sinclair Pharma has reported H1 ##M revenues of £ 22 m ( $ 27.2 m ) , an increase of 16 % on last year 's figure of £ 20 m . The increase is attributed to strong demand for Sinclair 's aesthetic dermatology products in Brazil . Sinclair also said Silhouette Soft sales were up 20 % to £ 7.3 m , and first - sales for Silhouette InstaLift hit £ 2.3 m . Even better results are expected in the second half of the year , according to CEO Chris Smith .